Cargando…

Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination

The delivery of strong HPV vaccine recommendations hinges on the expertise of healthcare providers (HCPs) in assessing patients’ status and recommending HPV vaccination. We conducted a population-based cross-sectional study of HCPs practicing in Texas to examine the relationship between HPV vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osaghae, Ikponmwosa, Darkoh, Charles, Chido-Amajuoyi, Onyema Greg, Chan, Wenyaw, Wermuth, Paige Padgett, Pande, Mala, Cunningham, Sonia a, Shete, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	HPV – Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746413/ https://www.ncbi.nlm.nih.gov/pubmed/36265005 http://dx.doi.org/10.1080/21645515.2022.2132755

Ejemplares similares

HPV Vaccination Training of Healthcare Providers and Perceived Self-Efficacy in HPV Vaccine-Hesitancy Counseling
por: Osaghae, Ikponmwosa, et al.
Publicado: (2022)

Healthcare Provider’s Perceived Self-Efficacy in HPV Vaccination Hesitancy Counseling and HPV Vaccination Acceptance
por: Osaghae, Ikponmwosa, et al.
Publicado: (2023)

The influence of political ideology on awareness of HPV and HPV vaccine among adults in the United States
por: Chido-Amajuoyi, Onyema Greg, et al.
Publicado: (2023)

Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic
por: Osaghae, Ikponmwosa, et al.
Publicado: (2022)

Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020
por: Osaghae, Ikponmwosa, et al.
Publicado: (2023)

Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities
por: Osaghae, Ikponmwosa, et al.
Publicado: (2023)

The influence of parent–child gender on intentions to refuse HPV vaccination due to safety concerns/side effects, National Immunization Survey – Teen, 2010–2019
por: Chido-Amajuoyi, Onyema Greg, et al.
Publicado: (2022)

Declining awareness of HPV and HPV vaccine within the general US population
por: Chido-Amajuoyi, Onyema Greg, et al.
Publicado: (2020)

HPV vaccine recommendations by age: A survey of providers in federally qualified health centers
por: Lake, Paige, et al.
Publicado: (2023)

HPV Vaccination Uptake, Hesitancy, and Refusal: Observations of Health-Care Professionals During the COVID-19 Pandemic
por: Chido-Amajuoyi, Onyema Greg, et al.
Publicado: (2022)

Reasons patients cite to their health-care professional for not initiating or completing human papillomavirus vaccination
por: Chido-Amajuoyi, Onyema Greg, et al.
Publicado: (2023)

Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series
por: Kajtezovic, Sidika, et al.
Publicado: (2023)

Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10
por: Kahn, Benjamin Z., et al.
Publicado: (2023)

How to make effective HPV vaccine recommendations starting at age 9
por: Brewer, Noel T., et al.
Publicado: (2023)

Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
por: O’Leary, Sonja C., et al.
Publicado: (2023)

HPV vaccine knowledge, attitudes, and practices among New York State medical providers, dentists, and pharmacists
por: Fernandes, Annlynn, et al.
Publicado: (2023)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
por: Goldstone, Stephen E.
Publicado: (2023)

Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities
por: Coyne-Beasley, Tamera, et al.
Publicado: (2023)

A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation
por: Ishimoto, Tatsuki, et al.
Publicado: (2023)

HPV vaccine information, knowledge, attitude, and recommendation intention among male college students in China
por: Wu, Huamei, et al.
Publicado: (2023)

Knowledge of HPV, its vaccines, and attitudes toward HPV vaccines among obstetrician-gynecologists, pediatricians and immunization services providers in Western China
por: Ma, Jianqiao, et al.
Publicado: (2021)

Feminized vaccine? Parents’ attitudes toward HPV vaccination of adolescents in Poland: A representative study
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Engaging health plans to prioritize HPV vaccination and initiate at age 9
por: Foley, Shaylen, et al.
Publicado: (2023)

Changing trends in HPV vaccination in Japan
por: Ujiie, Mugen, et al.
Publicado: (2021)

An ethics of HPV vaccination: beyond principlism
por: Stoeklé, Henri-Corto, et al.
Publicado: (2022)

Beliefs About HPV Vaccine’s Success at Cervical Cancer Prevention Among Adult US Women
por: Fokom Domgue, Joël, et al.
Publicado: (2019)

Parents’ stigmatizing beliefs about the HPV vaccine and their association with information seeking behavior and vaccination communication behaviors
por: McKenzie, Ashley Hedrick, et al.
Publicado: (2023)

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
por: Shi, Li-Wei, et al.
Publicado: (2023)

Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen
por: Bednarczyk, Robert A., et al.
Publicado: (2023)

Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer
por: Du, Eric Y., et al.
Publicado: (2022)

Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs
por: Alsanafi, Mariam, et al.
Publicado: (2023)

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong
por: Cheung, Tak Hong, et al.
Publicado: (2023)

Implementing interventions to start HPV vaccination at age 9: Using the evidence we have
por: Brandt, Heather M., et al.
Publicado: (2023)

Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration
por: Miller, Meagan E., et al.
Publicado: (2023)

Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
por: Eun, Byung-Wook, et al.
Publicado: (2023)

The use of urine in the follow-up of HPV vaccine trials
por: Vorsters, Alex, et al.
Publicado: (2015)

1641. A Comparison of Human Papilloma Virus Infection Prevalence Trends Pre- and Post-HPV Vaccine Implementation
por: Ovie. Fueta, Patrick, et al.
Publicado: (2019)

Healthcare providers’ practice protocols, strategies, and needed tools to address parental HPV vaccine hesitancy: An exploratory study
por: Cunningham-Erves, Jennifer, et al.
Publicado: (2022)

Systematic review of the cost-effectiveness of the vaccination against HPV in Brazil
por: Fonseca, Allex Jardim, et al.
Publicado: (2014)

Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9
por: O’Leary, Sean T.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08neqmontdh5lengic3d7haags